Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response (2011)
- Authors:
- Rodrigues, Alice Cristina
- Perin, Paula Monteiro dos Santos
- Purim, Sheila Gregório
- Silbiger, Vivian Nogueira
- Genvigir, Fabiana Dalla Vecchia
- Willrich, Maria Alice Vieira
- Arazi, Simone Sorkin
- Luchessi, André Ducati
- Hirata, Mario Hiroyuki
- Bernik, Marcia Martins Silveira
- Dórea, Egidio Lima
- Santos, Carla
- Faludi, André A - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Bertolami, Marcelo C - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Salas, Antonio
- Freire, Ana
- Lareu, Maria V
- Phillips, Christopher
- Porras-Hurtado, Liliana
- Fondevila, Manuel
- Carracedo, Angel
- Hirata, Rosario Dominguez Crespo
- Rodrigues, Alice Cristina
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- DOI: 10.3390/ijms12095815
- Subjects: FARMACOTÉCNICA; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: International Journal of Molecular Sciences
- ISSN: 1422-0067
- Volume/Número/Paginação/Ano: v. 12, p. 5815-5827, 2011
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
RODRIGUES, Alice Cristina et al. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. International Journal of Molecular Sciences, v. 12, p. 5815-5827, 2011Tradução . . Disponível em: https://doi.org/10.3390/ijms12095815. Acesso em: 17 abr. 2024. -
APA
Rodrigues, A. C., Perin, P. M. dos S., Purim, S. G., Silbiger, V. N., Genvigir, F. D. V., Willrich, M. A. V., et al. (2011). Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. International Journal of Molecular Sciences, 12, 5815-5827. doi:10.3390/ijms12095815 -
NLM
Rodrigues AC, Perin PM dos S, Purim SG, Silbiger VN, Genvigir FDV, Willrich MAV, Arazi SS, Luchessi AD, Hirata MH, Bernik MMS, Dórea EL, Santos C, Faludi AA, Bertolami MC, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevila M, Carracedo A, Hirata RDC. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response [Internet]. International Journal of Molecular Sciences. 2011 ; 12 5815-5827.[citado 2024 abr. 17 ] Available from: https://doi.org/10.3390/ijms12095815 -
Vancouver
Rodrigues AC, Perin PM dos S, Purim SG, Silbiger VN, Genvigir FDV, Willrich MAV, Arazi SS, Luchessi AD, Hirata MH, Bernik MMS, Dórea EL, Santos C, Faludi AA, Bertolami MC, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevila M, Carracedo A, Hirata RDC. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response [Internet]. International Journal of Molecular Sciences. 2011 ; 12 5815-5827.[citado 2024 abr. 17 ] Available from: https://doi.org/10.3390/ijms12095815 - Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
- Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
Informações sobre o DOI: 10.3390/ijms12095815 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
